Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROTECTIVE EFFICACY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 248 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McMurray, DN
      A coordinated strategy for evaluating new vaccines for human and animal tuberculosis

      TUBERCULOSIS
    2. Andersen, P
      TB vaccines: progress and problems

      TRENDS IN IMMUNOLOGY
    3. Schirmbeck, R; Reimann, J
      Revealing the potential of DNA-based vaccination: Lessons learned from thehepatitis B virus surface antigen

      BIOLOGICAL CHEMISTRY
    4. Pierce, AB; Hoy, JF
      Is the recommendation for pneumococcal vaccination of HIV patients evidence based?

      JOURNAL OF CLINICAL VIROLOGY
    5. Xing, Z
      The hunt for new tuberculosis vaccines: Anti-TB immunity and rational design of vaccines

      CURRENT PHARMACEUTICAL DESIGN
    6. Lawrence, RN
      New hope for fungal vaccines?

      DRUG DISCOVERY TODAY
    7. Kandel, R; Hartshorn, KL
      Prophylaxis and treatment of influenza virus infection

      BIODRUGS
    8. Rubins, JB; Janoff, EN
      Pneumococcal disease in the elderly - What is preventing vaccine efficacy?

      DRUGS & AGING
    9. Jarosinski, KW; Jia, W; Sekellick, MJ; Marcus, PI; Schat, KA
      Cellular responses in chickens treated with IFN-alpha orally or inoculatedwith recombinant Marek's disease virus expressing IFN-alpha

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    10. Gilbert, P; Self, S; Rao, M; Naficy, A; Clemens, J
      Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    11. Poland, GA
      The prevention of pneumococcal disease by vaccines: Promises and challenges

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    12. Greenberg, DP
      Considerations for hepatitis B as part of a combination vaccine

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    13. Leophonte, P; Neukirch, F
      Anti-pneumococci vaccination: role and indications in the prevention of community acquired infections of the lower respiratory tract.

      MEDECINE ET MALADIES INFECTIEUSES
    14. Andersson, C; Vasconcelos, NM; Sievertzon, M; Haddad, D; Liljeqvist, S; Berglund, P; Liljestrom, P; Ahlborg, N; Stahl, S; Berzins, K
      Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    15. Page, M; Jones, CD; Bailey, C
      A novel, recombinant triple antigen hepatitis B vaccine (Hepacare((R)))

      INTERVIROLOGY
    16. de Kleijn, E; van Eijndhoven, L; Vermont, C; Kuipers, B; van Dijken, H; Rumke, H; de Groot, R; van Alphen, L; van den Dobbelsteen, G
      Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesiclevaccine

      VACCINE
    17. Madalinski, K; Sylvan, SPE; Hellstrom, U; Mikolajewicz, J; Zembrzuska-Sadkowska, E; Piontek, E
      Antibody responses to preS components after immunization of children with low doses of BioHepB

      VACCINE
    18. Aguiar, JC; Hedstrom, RC; Rogers, WO; Charoenvit, Y; Sacci, JB; Lanar, DE; Majam, VF; Stout, RR; Hoffman, SL
      Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

      VACCINE
    19. Schneider, J; Langermans, JAM; Gilbert, SC; Blanchard, TJ; Twigg, S; Naitza, S; Hannan, CM; Aidoo, M; Crisanti, A; Robson, KJ; Smith, GL; Hill, AVS; Thomas, AW
      A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

      VACCINE
    20. Cornu, C; Yzebe, D; Leophonte, P; Gaillat, J; Boissel, JP; Cucherat, M
      Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults:a meta-analysis of randomized trials

      VACCINE
    21. Yamada, T; Iwabuki, H; Kanno, T; Tanaka, H; Kawai, T; Fukuda, H; Kondo, A; Seno, M; Tanizawa, K; Kuroda, S
      Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1+pre-S2+S) protein

      VACCINE
    22. Garapin, AC; Ma, L; Pescher, P; Lagranderie, M; Marchal, G
      Mixed immune response induced in rodents by two naked DNA genes coding formycobacterial glycosylated proteins

      VACCINE
    23. Peeters, BPH; de Leeuw, OS; Verstegen, I; Koch, G; Gielkens, ALJ
      Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals

      VACCINE
    24. Gherardi, MM; Ramirez, JC; Esteban, M
      Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant toenhance cellular immune responses to pathogens during prime-booster vaccination regimens

      HISTOLOGY AND HISTOPATHOLOGY
    25. Wilson, JN; Nokes, DJ; Dimmock, NJ
      Analysis of the relationship between immunogenicity and immunity for viralsubunit vaccines

      JOURNAL OF MEDICAL VIROLOGY
    26. Shenson, D; Quinley, J; DiMartino, D; Stumpf, P; Caldwell, M; Lee, T
      Pneumococcal immunizations at flu clinics: The impact of community-wide outreach

      JOURNAL OF COMMUNITY HEALTH
    27. Couillin, I; Letourneur, F; Lefebvre, P; Guillet, JG; Martinon, F
      DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses

      VIROLOGY
    28. Penny, ME; Murad, S; Madrid, SS; Herrera, TS; Pineiro, A; Caceres, DE; Lanata, CF
      Respiratory symptoms, asthma, exercise test spirometry, and atopy in schoolchildren from a Lima shanty town

      THORAX
    29. Ulmer, JB
      Tuberculosis DNA vaccines

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    30. Ada, G
      Advances in immunology - Vaccines and vaccination

      NEW ENGLAND JOURNAL OF MEDICINE
    31. Clemens, JD; Sack, DA; Ivanoff, B
      Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru

      JOURNAL OF INFECTIOUS DISEASES
    32. Taylor, DN; Sanchez, J; Cardenas, V; Gilman, RE; Sadoff, J
      Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru - Reply

      JOURNAL OF INFECTIOUS DISEASES
    33. Hel, Z; Tsai, WP; Thornton, A; Nacsa, J; Giuliani, L; Tryniszewska, E; Poudyal, M; Venzon, D; Wang, XC; Altman, J; Watkins, DI; Lu, WH; von Gegerfelt, A; Felber, BK; Tartaglia, J; Pavlakis, GN; Franchini, G
      Potentiation of simian immunodeficiency virus (SIV)-speciific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

      JOURNAL OF IMMUNOLOGY
    34. Eo, SK; Gierynska, M; Abou Kamar, A; Rouse, BT
      Prime-boost immunization with DNA vaccine: Mucosal route of administrationchanges the rules

      JOURNAL OF IMMUNOLOGY
    35. Miyauchi, S; Ito, M; Sakamoto, T
      The optimal molecular weight of dispersive type sodium hyaluronate for thereduction of corneal endothelial damage induced by sonication, irrigation,and aspiration

      JAPANESE JOURNAL OF OPHTHALMOLOGY
    36. Delogu, G; Brennan, MJ
      Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis

      INFECTION AND IMMUNITY
    37. Fonseca, DPAJ; Benaissa-Trouw, B; Van Engelen, M; Kraaijeveld, CA; Snippe, H; Verheul, AFM
      Induction of cell-mediated immunity against mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein

      INFECTION AND IMMUNITY
    38. Sun, Y; Hwang, YI; Nahm, MH
      Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B

      INFECTION AND IMMUNITY
    39. Valle, MT; Megiovanni, AM; Merlo, A; Pira, GL; Bottone, L; Angelini, G; Bracci, L; Lozzi, L; Huygen, K; Manca, F
      Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    40. Hanke, T
      Prospect of a prophylactic vaccine for HIV

      BRITISH MEDICAL BULLETIN
    41. Simmons, M; Murphy, GS; Kochel, T; Raviprakash, K; Hayes, CG
      Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    42. Simmons, M; Murphy, GS; Hayes, CG
      Short report: Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    43. Klein, BS
      Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion

      CURRENT OPINION IN MICROBIOLOGY
    44. Pillai, DR; Kain, KC
      Recent developments in amoebiasis: the Gal/GalNAc lectins of Entamoeba histolytica and Entamoeba dispar

      MICROBES AND INFECTION
    45. Kaufmann, SHE
      Is the development of a new tuberculosis vaccine possible?

      NATURE MEDICINE
    46. Ament, A; Baltussen, R; Duru, G; Rigaud-Bully, C; de Graeve, D; Ortqvist, A; Jonsson, B; Verhaegen, J; Gaillat, J; Christie, P; Cifre, AS; Vivas, D; Loiseau, C; Fedson, DS
      Cost-effectiveness of pneumococcal vaccination of older people: A study in5 western European countries

      CLINICAL INFECTIOUS DISEASES
    47. Brown, M; Zhang, Y; Dermine, S; de Wynter, EA; Hart, C; Kitchener, H; Stern, PL; Skinner, MA; Stacey, SN
      Dendritic cells infected with recombinant fowlpox virus vectors are potentand long-acting stimulators of transgene-specific class I restricted T lymphocyte activity

      GENE THERAPY
    48. McMichael, AJ; Callan, M; Appay, V; Hanke, T; Ogg, G; Rowland-Jones, S
      The dynamics of the cellular immune response to HIV infection: implications for vaccination

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    49. Hayes, RJ; Alexander, NDE; Bennett, S; Cousens, SN
      Design and analysis issues in cluster-randomized trials of interventions against infectious diseases

      STATISTICAL METHODS IN MEDICAL RESEARCH
    50. Perlmann, P; Bjorkman, A
      Malaria research: host-parasite interactions and new developments in chemotherapy, immunology and vaccinology

      CURRENT OPINION IN INFECTIOUS DISEASES
    51. Mufson, MA
      Antibody response of pneumococcal vaccine: need for booster dosing?

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    52. Stevenson, KB; McMahon, JW; Harris, J; Hillman, JR; Helgerson, SD
      Increasing pneumococcal vaccination rates among residents of long-term-care facilities: Provider-based improvement strategies implemented by peer-review organizations in four western states

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    53. Triccas, JA; Gicquel, B
      Life on the inside: Probing Mycobacterium tuberculosis gene expression during infection

      IMMUNOLOGY AND CELL BIOLOGY
    54. Smith, SM; Dockrell, HM
      Role of CD8(+) T cells in mycobacterial infections

      IMMUNOLOGY AND CELL BIOLOGY
    55. Collins, DM
      New tuberculosis vaccines based on attenuated strains of the Mycobacteriumtuberculosis complex

      IMMUNOLOGY AND CELL BIOLOGY
    56. Safary, A; Beck, J
      Vaccination against hepatitis B: Current challenges for Asian countries and future directions

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    57. Krieger, JW; Castorina, JS; Walls, ML; Weaver, MR; Ciske, S
      Increasing influenza and pneumococcal immunization rates: A randomized controlled study of a senior center-based intervention

      AMERICAN JOURNAL OF PREVENTIVE MEDICINE
    58. Britton, WJ; Martin, E; Kamath, AT; Neupane, KD; Roche, PW
      Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines

      LEPROSY REVIEW
    59. Skogerboe, TL; Smith, LL; Karle, VK; Derozier, CL
      The persistent efficacy of doramectin pour-on against biting and sucking louse infestations of cattle

      VETERINARY PARASITOLOGY
    60. Borowicz, KK; Stasiuk, G; Teter, J; Kleinrok, Z; Gasior, M; Czuczwar, SJ
      Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice

      JOURNAL OF NEURAL TRANSMISSION
    61. Hope, JC; Kwong, LS; Sopp, P; Collins, RA; Howard, CJ
      Dendritic cells induce CD4(+) and CD8(+) T-cell responses to Mycobacteriumbovis and M-Avium antigens in Bacille Calmette Guerin vaccinated and nonvaccinated cattle

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    62. Barouch, DH; Letvin, NL
      DNA vaccination for HIV-1 and SIV

      INTERVIROLOGY
    63. Vordermeier, HM; Cockle, PJ; Whelan, AO; Rhodes, S; Chambers, MA; Clifford, D; Huygen, K; Tascon, R; Lowrie, D; Colston, MJ; Hewinson, RG
      Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test

      VACCINE
    64. Boyce, TG; Hsu, HH; Sannella, EC; Coleman-Dockery, SD; Baylis, E; Zhu, YW; Barchfeld, O; DiFrancesco, A; Paranandi, M; Culley, B; Neuzil, KM; Wright, PF
      Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenzavaccines administered intranasally to healthy adults

      VACCINE
    65. Austrian, R
      Pneumococcal otitis media and pneumococcal vaccines, a historical perspective

      VACCINE
    66. Goetsch, L; Plotnicky-Gilquin, H; Champion, T; Beck, A; Corvaia, N; Stahl, S; Bonnefoy, JY; Nguyen, TN; Power, UF
      Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunitvaccine candidate

      VACCINE
    67. Martin, SL; Borrow, R; van der Ley, P; Dawson, M; Fox, AJ; Cartwright, KAV
      Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine

      VACCINE
    68. Ambrosch, F; Wiedermann, G; Kundi, M; Leroux-Roels, G; Desombere, I; Garcon, N; Thiriart, C; Slaoui, M; Thoelen, S
      A hepatitis B vaccine formulated with a novel adjuvant system

      VACCINE
    69. Chen, CH; Wang, TL; Hung, CF; Pardoll, DM; Wu, TC
      Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines

      VACCINE
    70. Gonzalez, IM; Karron, RA; Eichelberger, M; Walsh, EE; Delagarza, VW; Bennett, R; Chanock, RM; Murphy, BR; Clements-Mann, ML; Falsey, AR
      Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults

      VACCINE
    71. Anders, RF; Saul, A
      Malaria vaccines

      PARASITOLOGY TODAY
    72. Ramshaw, IA; Ramsay, AJ
      The prime-boost strategy: exciting prospects for improved vaccination

      IMMUNOLOGY TODAY
    73. Vidalin, O; Fournillier, A; Renard, N; Chen, M; Depla, E; Boucreux, D; Brinster, C; Baumert, T; Nakano, I; Fukuda, Y; Liljestrom, P; Trepo, C; Inchauspe, G
      Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki Forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens

      VIROLOGY
    74. Williamson, C; Morris, L; Rybicki, E; Williamson, AL
      Designing HIV-1 subtype C vaccines for South Africa

      SOUTH AFRICAN JOURNAL OF SCIENCE
    75. Sullivan, NJ; Sanchez, A; Rollin, PE; Yang, ZY; Nabel, GJ
      Development of a preventive vaccine for Ebola virus infection in primates

      NATURE
    76. Seth, A; Ourmanov, I; Schmitz, JE; Kuroda, MJ; Lifton, MA; Nickerson, CE; Wyatt, L; Carroll, M; Moss, B; Venzon, D; Letvin, NL; Hirsch, VM
      Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

      JOURNAL OF VIROLOGY
    77. Ourmanov, I; Bilska, M; Hirsch, VM; Montefiori, DC
      Recombinant modified vaccinia virus Ankara expressing the surface gp120 ofsimian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques

      JOURNAL OF VIROLOGY
    78. Gherardi, MM; Ramirez, JC; Esteban, M
      Interleukin-12 (IL-12) enhancement of the cellular immune response againsthuman immunodeficiency virus type 1 Env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: Suppressive effects of IL-12 boost are mediated by nitric oxide

      JOURNAL OF VIROLOGY
    79. Qiu, JT; Liu, BD; Tian, CJ; Pavlakis, GN; Yu, XF
      Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 Gag by using DNA expression vectors that target Gag antigen to the secretory pathway

      JOURNAL OF VIROLOGY
    80. Musher, DM; Phan, HM; Watson, DA; Baughn, RE
      Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for pneumococcal pneumonia

      JOURNAL OF INFECTIOUS DISEASES
    81. Allen, TM; Vogel, TU; Fuller, DH; Mothe, BR; Steffen, S; Boyson, JE; Shipley, T; Fuller, J; Hanke, T; Sette, A; Altman, JD; Moss, B; McMichael, AJ; Watkins, DI
      Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

      JOURNAL OF IMMUNOLOGY
    82. Wilkinson, KA; Belisle, JT; Mincek, M; Wilkinson, RJ; Toossi, Z
      Enhancement of the human T cell response to culture filtrate fractions of Mycobacterium tuberculosis by microspheres

      JOURNAL OF IMMUNOLOGICAL METHODS
    83. Wuthrich, M; Filutowicz, HI; Klein, BS
      Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance

      JOURNAL OF CLINICAL INVESTIGATION
    84. Mustafa, AS; Shaban, FA; Abal, AT; Al-Attiyah, R; Wiker, HG; Lundin, KEA; Oftung, F; Huygen, K
      Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines

      INFECTION AND IMMUNITY
    85. Delogu, G; Howard, A; Collins, FM; Morris, SL
      DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugatedtuberculosis protein enhances antimycobacterial immunity

      INFECTION AND IMMUNITY
    86. Billson, FM; Harbour, C; Michalski, WP; Tennent, JM; Egerton, JR; Hodgson, JL
      Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody

      INFECTION AND IMMUNITY
    87. D'Souza, S; Denis, O; Scorza, T; Nzabintwali, F; Verschueren, H; Huygen, K
      CD4(+) T cells contain Mycobacterium tuberculosis infection in the absenceof CD8(+) T cells in mice vaccinated with DNA encoding Ag85A

      EUROPEAN JOURNAL OF IMMUNOLOGY
    88. Marra, CA; Patrick, DM; Marra, F
      A cost-effectiveness analysis of pneumococcal vaccination in street-involved, HIV-infected patients

      CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
    89. Breiman, RF; Keller, DW; Phelan, MA; Sniadack, DH; Stephens, DS; Rimland, D; Farley, MM; Schuchat, A; Reingold, AL
      Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

      ARCHIVES OF INTERNAL MEDICINE
    90. Carson, PJ; Nichol, KL; O'Brien, J; Hilo, P; Janoff, EN
      Immune function and vaccine responses in healthy advanced elderly patients

      ARCHIVES OF INTERNAL MEDICINE
    91. San Gil, F; Turner, B; Walker, MJ; Djordjevic, SP; Chin, JC
      Contribution of adjuvant to adaptive immune responses in mice against Actinobacillus pleuropneumoniae

      MICROBIOLOGY-UK
    92. Honkanen, PO; Makela, PH
      Pneumococcal vaccination in the elderly - An underused option?

      BIODRUGS
    93. Austrian, R
      A brief history of pneumococcal vaccines

      DRUGS & AGING
    94. Fedson, DS
      Pneumococcal vaccination for older adults - The first 20 years

      DRUGS & AGING
    95. McMichael, AJ; Hanke, T
      Is an HIV vaccine possible?

      NATURE MEDICINE
    96. Robinson, HL; Montefiori, DC; Johnson, RP; Manson, KH; Kalish, ML; Lifson, JD; Rizvi, TA; Lu, S; Hu, SL; Mazzara, GP; Panicali, DL; Herndon, JG; Glickman, R; Candido, MA; Lydy, SL; Wyand, MS; McClure, HM
      Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

      NATURE MEDICINE
    97. Wandstrat, TL; Kaplan-Machlis, B; Temple, ME; Nahata, MC
      Tetravalent rotavirus vaccine

      ANNALS OF PHARMACOTHERAPY
    98. Butler, JC; Cetron, MS
      Pneumococcal drug resistance: The new "special enemy of old age"

      CLINICAL INFECTIOUS DISEASES
    99. Borowicz, KK; Kleinrok, Z; Czuczwar, SJ
      Influence of 3-PPP, a sigma receptor ligand, on the anticonvulsive action of conventional antiepileptic drugs

      PHARMACOLOGICAL RESEARCH
    100. Rohani, MY; Raudzah, A; Ng, AJ; Ng, PP; Zaidatul, AAR; Asmah, I; Murtaza, M; Parasakthy, N; Yasmin, MYM; Cheong, YM
      Epidemiology of Streptococcus pneumoniae infection in Malaysia

      EPIDEMIOLOGY AND INFECTION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 19:21:56